Lyme Disease & Hyperbaric Oxygen Therapy

Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted through the bite of infected black-legged ticks. Vermont is among the highest-risk states for Lyme disease, making it a significant health concern for our community. While early-stage Lyme disease often responds well to antibiotics, many patients develop chronic or persistent symptoms that can be debilitating.

Chronic Lyme disease (also referred to as Post-Treatment Lyme Disease Syndrome) can cause ongoing fatigue, joint and muscle pain, cognitive difficulties, neurological symptoms, and other complications that significantly impact quality of life. These persistent symptoms are believed to result from residual inflammation, immune dysfunction, and tissue damage caused by the initial infection.

Standard antibiotic therapy alone may not fully resolve symptoms in chronic cases, leading patients and clinicians to explore adjunctive therapies like Hyperbaric Oxygen Therapy to support healing and recovery.

Chronic and refractory Lyme disease presents one of the most complex challenges in modern medicine. When standard antibiotic protocols fail to resolve symptoms, a multidisciplinary approach becomes essential. At Green Mountain Hyperbaric & Advanced Wound Care, we believe in addressing persistent Lyme disease through multiple therapeutic pathways simultaneously.

Hyperbaric oxygen therapy (HBOT) plays a central role in this approach by creating an oxygen-rich environment that is inhospitable to Borrelia burgdorferi, the spirochete responsible for Lyme disease. Under increased atmospheric pressure, dissolved oxygen penetrates deep into tissues—including the central nervous system, joints, and connective tissues where Lyme bacteria often persist in biofilm communities that shield them from antibiotics.

A comprehensive treatment plan for chronic Lyme may integrate HBOT with antimicrobial therapy, immune system support, nutritional optimization, and neurological rehabilitation. This combined strategy targets the infection from multiple angles: HBOT disrupts bacterial biofilms and enhances antibiotic penetration, while simultaneously reducing the neuroinflammation and oxidative stress that drive many of the debilitating symptoms patients experience—brain fog, fatigue, joint pain, and neuropathy.

Emerging clinical evidence suggests that patients who receive HBOT as part of an integrative protocol often experience meaningful improvements in cognitive function, energy levels, and overall quality of life—even after years of persistent symptoms. By working collaboratively with infectious disease specialists, neurologists, and integrative medicine practitioners, we help develop individualized treatment plans tailored to each patient's unique presentation.

Explore a Multidisciplinary Treatment Plan

If you or a loved one is struggling with chronic or refractory Lyme disease, our team can help evaluate whether hyperbaric oxygen therapy—combined with a coordinated, multidisciplinary approach—may offer a path forward.

Borrelia burgdorferi is a highly adaptable bacterium that can evade the immune system and persist in tissues even after antibiotic treatment. The spirochete form of the bacteria can shift into protective cyst and biofilm forms that are resistant to standard antibiotics.

Chronic Lyme disease involves a complex interplay of persistent low-grade infection, autoimmune activation, chronic inflammation, and tissue hypoxia. The resulting damage to joints, nerves, and other tissues creates ongoing symptoms that can last months or years after the initial infection.

The bacteria thrive in low-oxygen environments, which is one reason HBOT has gained attention as a potential treatment—by dramatically increasing tissue oxygen levels, the environment becomes inhospitable to the organism while simultaneously supporting tissue repair.

Hyperbaric Oxygen Therapy targets several key mechanisms of chronic Lyme disease. Borrelia burgdorferi is a microaerophilic organism—it thrives in low-oxygen conditions. HBOT saturates tissues with oxygen, creating an environment that is directly hostile to the bacteria and may help eliminate persistent organisms.

Beyond its direct antimicrobial effects, HBOT powerfully modulates the immune system and reduces chronic inflammation. It enhances white blood cell function, promotes the release of growth factors, and supports the repair of damaged nerves, joints, and other tissues affected by Lyme disease.

Published case studies and clinical reports have documented significant improvements in patients with chronic Lyme disease following HBOT, including reduced pain, improved energy levels, better cognitive function, and resolution of neurological symptoms. HBOT works well as an adjunctive therapy alongside antibiotic and other treatments.

Published Research & Clinical Studies